Table of Contents

2019-2024 Global Osteoarthritis Therapeutics Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Osteoarthritis Therapeutics Market Size 2014-2024
2.1.2 Osteoarthritis Therapeutics Market Size CAGR by Region
2.2 Osteoarthritis Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External
2.3 Osteoarthritis Therapeutics Market Size by Type
2.3.1 Global Osteoarthritis Therapeutics Market Size Market Share by Type (2014-2019)
2.3.2 Global Osteoarthritis Therapeutics Market Size Growth Rate by Type (2014-2019)
2.4 Osteoarthritis Therapeutics Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Osteoarthritis Therapeutics Market Size by Application
2.5.1 Global Osteoarthritis Therapeutics Market Size Market Share by Application (2014-2019)
2.5.2 Global Osteoarthritis Therapeutics Market Size Growth Rate by Application (2014-2019)

3 Global Osteoarthritis Therapeutics by Players
3.1 Global Osteoarthritis Therapeutics Market Size Market Share by Players
3.1.1 Global Osteoarthritis Therapeutics Market Size by Players (2017-2019)
3.1.2 Global Osteoarthritis Therapeutics Market Size Market Share by Players (2017-2019)
3.2 Global Osteoarthritis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Osteoarthritis Therapeutics by Regions
4.1 Osteoarthritis Therapeutics Market Size by Regions
4.2 Americas Osteoarthritis Therapeutics Market Size Growth
4.3 APAC Osteoarthritis Therapeutics Market Size Growth
4.4 Europe Osteoarthritis Therapeutics Market Size Growth
4.5 Middle East & Africa Osteoarthritis Therapeutics Market Size Growth

5 Americas
5.1 Americas Osteoarthritis Therapeutics Market Size by Countries
5.2 Americas Osteoarthritis Therapeutics Market Size by Type
5.3 Americas Osteoarthritis Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Osteoarthritis Therapeutics Market Size by Countries
6.2 APAC Osteoarthritis Therapeutics Market Size by Type
6.3 APAC Osteoarthritis Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Osteoarthritis Therapeutics by Countries
7.2 Europe Osteoarthritis Therapeutics Market Size by Type
7.3 Europe Osteoarthritis Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Osteoarthritis Therapeutics by Countries
8.2 Middle East & Africa Osteoarthritis Therapeutics Market Size by Type
8.3 Middle East & Africa Osteoarthritis Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Osteoarthritis Therapeutics Market Forecast
10.1 Global Osteoarthritis Therapeutics Market Size Forecast (2019-2024)
10.2 Global Osteoarthritis Therapeutics Forecast by Regions
10.2.1 Global Osteoarthritis Therapeutics Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Osteoarthritis Therapeutics Forecast by Type
10.8 Global Osteoarthritis Therapeutics Forecast by Application

11 Key Players Analysis
11.1 Pfizer
11.1.1 Company Details
11.1.2 Osteoarthritis Therapeutics Product Offered
11.1.3 Pfizer Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Pfizer News
11.2 Johnson & Johnson
11.2.1 Company Details
11.2.2 Osteoarthritis Therapeutics Product Offered
11.2.3 Johnson & Johnson Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Johnson & Johnson News
11.3 GlaxoSmithKline
11.3.1 Company Details
11.3.2 Osteoarthritis Therapeutics Product Offered
11.3.3 GlaxoSmithKline Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 GlaxoSmithKline News
11.4 Bayer
11.4.1 Company Details
11.4.2 Osteoarthritis Therapeutics Product Offered
11.4.3 Bayer Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Bayer News
11.5 Eli Lilly
11.5.1 Company Details
11.5.2 Osteoarthritis Therapeutics Product Offered
11.5.3 Eli Lilly Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Eli Lilly News
11.6 Novartis
11.6.1 Company Details
11.6.2 Osteoarthritis Therapeutics Product Offered
11.6.3 Novartis Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Novartis News
11.7 Sanofi
11.7.1 Company Details
11.7.2 Osteoarthritis Therapeutics Product Offered
11.7.3 Sanofi Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Sanofi News
11.8 Horizon Pharma
11.8.1 Company Details
11.8.2 Osteoarthritis Therapeutics Product Offered
11.8.3 Horizon Pharma Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Horizon Pharma News
11.9 Abbott
11.9.1 Company Details
11.9.2 Osteoarthritis Therapeutics Product Offered
11.9.3 Abbott Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Abbott News
11.10 Mylan
11.10.1 Company Details
11.10.2 Osteoarthritis Therapeutics Product Offered
11.10.3 Mylan Osteoarthritis Therapeutics Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Mylan News
11.11 Daiichi Sankyo
11.12 TEVA
11.13 Almatica Pharma
11.14 Astellas Pharma
11.15 Tide Pharmaceutical
11.16 Iroko Pharmaceuticals
11.17 Hengrui Pharmaceutical
11.18 Abiogen Pharma

12 Research Findings and Conclusion